4:35
Mainz Biomed & Liquid Biosciences Use AI To Develop Next-Generation Colorectal Screening Test
Benzinga Partner Studio
1:55
Mainz BioMed Works To Ensure Early Cancer Detection W/ 90% 5 Year Survival By Improving Test Access
2:34
Mainz Biomed's $MYNZ Cutting-Edge Colorectal Cancer Test Applies for FDA Breakthrough Status
8:04
Mainz Biomed $MYNZ Introduces The Newest Addition To Their Team
3:35
Mainz Biomed $MYNZ Sets Sights On Transformative Growth With FDA Trial In 2025
1:51
Mainz Biomed $MYNZ & Thermo Fisher Partner On Next-Gen Colorectal Cancer Screening Product
